Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111036116> ?p ?o ?g. }
- W3111036116 endingPage "307" @default.
- W3111036116 startingPage "295" @default.
- W3111036116 abstract "ABSTRACTIntroduction: The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 represents a serious health issue worldwide, with more than 61 million cases and more than 1.4 million deaths since the beginning of the epidemic near the end of 2019. The scientific community strongly responded to this emergency situation with massive research efforts, mostly focused on diagnosis and clinical investigation of therapeutic solutions. In this scenario, drug repurposing played a crucial role in accelerating advanced clinical testing and shortening the time to access the regulatory review.Areas covered: This review covers the main and most successful drug repurposing approaches from a design, clinical, and regulatory standpoint. Available patents on repurposed drugs are also discussed.Expert opinion: Drug repurposing proved highly successful in response to the current pandemic, with remdesivir becoming the first specific antiviral drug approved for the treatment of COVID-19. In parallel, a number of drugs such as corticosteroids and low molecular weight heparin (LMWH) are used to treat hospitalized COVID-19 patients, while clinical testing of additional therapeutic options is ongoing. It is reasonably expected that these research efforts will deliver optimized and specific therapeutic tools that will increase the preparedness of health systems to possible future epidemics.KEYWORDS: COVID-19drug repurposingremdesivirantiviral drugscoronavirusSARS-CoV-2 Article highlightsCOVID-19 triggered massive research efforts in the search of effective drugs, diagnostic tools, and vaccines.Drug repurposing represented a powerful approach to accelerate the discovery of COVID-19 treatment options.Several clinical trials on COVID-19 management have been launched, most of which focused on repurposed drugs.Currently, COVID-19 is managed with antiviral drugs, or adjunctive drugs that treat the main symptoms.Remdesivir is the first specific antiviral agent against SARS-CoV-2 that received approval from regulatory authorities.Remdesivir became a successful example of drug repurposing, being approved for COVID-19 management in less than one year from the beginning of the pandemic.This box summarizes key points contained in the article.Reviewer disclosuresPeer reviewers on this manuscript have no relevant financial or other relationships to disclose.Declaration of interestThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties." @default.
- W3111036116 created "2020-12-21" @default.
- W3111036116 creator A5052014881 @default.
- W3111036116 creator A5054210125 @default.
- W3111036116 creator A5071370272 @default.
- W3111036116 creator A5083385698 @default.
- W3111036116 date "2020-12-31" @default.
- W3111036116 modified "2023-10-16" @default.
- W3111036116 title "Repurposing drugs for the management of COVID-19" @default.
- W3111036116 cites W2034411609 @default.
- W3111036116 cites W2056406352 @default.
- W3111036116 cites W2060514161 @default.
- W3111036116 cites W2074095102 @default.
- W3111036116 cites W2095807050 @default.
- W3111036116 cites W2100967823 @default.
- W3111036116 cites W2128830870 @default.
- W3111036116 cites W2147759897 @default.
- W3111036116 cites W2292021561 @default.
- W3111036116 cites W2725497285 @default.
- W3111036116 cites W2765166506 @default.
- W3111036116 cites W2791163322 @default.
- W3111036116 cites W2793022939 @default.
- W3111036116 cites W2793706941 @default.
- W3111036116 cites W2896002881 @default.
- W3111036116 cites W2913808052 @default.
- W3111036116 cites W2944466104 @default.
- W3111036116 cites W2998883241 @default.
- W3111036116 cites W3004280078 @default.
- W3111036116 cites W3004318991 @default.
- W3111036116 cites W3004919484 @default.
- W3111036116 cites W3008047170 @default.
- W3111036116 cites W3009906937 @default.
- W3111036116 cites W3010673910 @default.
- W3111036116 cites W3010930696 @default.
- W3111036116 cites W3012379316 @default.
- W3111036116 cites W3012953808 @default.
- W3111036116 cites W3013008917 @default.
- W3111036116 cites W3013486442 @default.
- W3111036116 cites W3013498471 @default.
- W3111036116 cites W3013899502 @default.
- W3111036116 cites W3014962324 @default.
- W3111036116 cites W3015087145 @default.
- W3111036116 cites W3015186638 @default.
- W3111036116 cites W3015218828 @default.
- W3111036116 cites W3015608194 @default.
- W3111036116 cites W3016885747 @default.
- W3111036116 cites W3017868191 @default.
- W3111036116 cites W3018023298 @default.
- W3111036116 cites W3018037557 @default.
- W3111036116 cites W3019049006 @default.
- W3111036116 cites W3020512604 @default.
- W3111036116 cites W3022285953 @default.
- W3111036116 cites W3022734398 @default.
- W3111036116 cites W3022916237 @default.
- W3111036116 cites W3023908803 @default.
- W3111036116 cites W3024506007 @default.
- W3111036116 cites W3025143393 @default.
- W3111036116 cites W3025511956 @default.
- W3111036116 cites W3027630905 @default.
- W3111036116 cites W3027858755 @default.
- W3111036116 cites W3029848232 @default.
- W3111036116 cites W3030325615 @default.
- W3111036116 cites W3035293132 @default.
- W3111036116 cites W3035763757 @default.
- W3111036116 cites W3037412082 @default.
- W3111036116 cites W3038084541 @default.
- W3111036116 cites W3038241707 @default.
- W3111036116 cites W3038261609 @default.
- W3111036116 cites W3038607673 @default.
- W3111036116 cites W3040116040 @default.
- W3111036116 cites W3042238480 @default.
- W3111036116 cites W3042747701 @default.
- W3111036116 cites W3043154997 @default.
- W3111036116 cites W3044118599 @default.
- W3111036116 cites W3044226918 @default.
- W3111036116 cites W3044927477 @default.
- W3111036116 cites W3045027513 @default.
- W3111036116 cites W3045075737 @default.
- W3111036116 cites W3045952783 @default.
- W3111036116 cites W3048152504 @default.
- W3111036116 cites W3048601848 @default.
- W3111036116 cites W3080677494 @default.
- W3111036116 cites W3081462415 @default.
- W3111036116 cites W3082246640 @default.
- W3111036116 cites W3082713933 @default.
- W3111036116 cites W3083605260 @default.
- W3111036116 cites W3085112856 @default.
- W3111036116 cites W3087156149 @default.
- W3111036116 cites W3089421034 @default.
- W3111036116 cites W3090929175 @default.
- W3111036116 cites W3091337946 @default.
- W3111036116 cites W3091659790 @default.
- W3111036116 cites W3092125766 @default.
- W3111036116 cites W3092171284 @default.
- W3111036116 cites W3093701219 @default.
- W3111036116 cites W3095075747 @default.
- W3111036116 cites W3098853825 @default.
- W3111036116 cites W3108582220 @default.